Filing Flows › Longevity Health Holdings (XAGE) › Q2 2026 › vs Q1 2026
Longevity Health Holdings (XAGE) Q2 2026 vs Q1 2026 (quarter over quarter)
Longevity Health Holdings's revenue rose $4K (+1%) from $392K in Q1 2026 to $396K in Q2 2026.
Longevity Health Holdings, Q2 2026: revenue $396K (-21% year over year), operating margin -182.9%, net loss $1.9M, operating cash flow −$224K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $396K | $392K | $4K | +1% |
| Net loss | $1.9M | $1.4M | $452K | +32% |
| Costs & expenses | $2.3M | $1.8M | $456K | +25% |
| Operating costs | $1.1M | $1.7M | −$600K | -35% |
| Interest & other, net | $1.2M | $103K | $1.1M | 11× |
| Cost of revenue | $160K | $155K | $6K | +4% |
| Research & development | $73K | $55K | $18K | +32% |
| Sales & marketing | $191K | $271K | −$79K | -29% |
| Other operating costs | $13K | $1.2M | −$1.2M | -99% |
| Operating cash sources | $1.9M | $1.4M | $452K | +32% |
| Depreciation & amortization | $13K | $15K | −$2K | -11% |
| Share-based compensation | $79K | $146K | −$67K | -46% |
| Working capital & other | $1.6M | $785K | $782K | +100% |
| Cash used in operations | $224K | $485K | −$261K | -54% |
| Net loss absorbed | $1.9M | $1.4M | $452K | +32% |
Questions
How much did Longevity Health Holdings's revenue grow quarter over quarter in Q2 2026?
Longevity Health Holdings's revenue rose $4K (+1%) from $392K in Q1 2026 to $396K in Q2 2026.